![Michael Tomsicek](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Michael Tomsicek
Director/Board Member at
MILESTONE PHARMACEUTICALS INC.
Net worth: 36 287 $ as of 2026-05-30
Profile
Mr. Michael J. Tomsicek is an Independent Non-Executive Director at Milestone Pharmaceuticals, Inc. and a CFO & Principal Accounting Officer at CRISPR Therapeutics AG. He is on the Board of Directors at Milestone Pharmaceuticals, Inc. and Optimer Pharmaceuticals LLC. Mr. Tomsicek was previously employed as a CFO, Treasurer, Principal Accounting Officer & VP by ABIOMED, Inc., a Treasurer by Cubist Pharmaceuticals, Inc., a CFO-Global Ultrasound Product Group by General Electric Healthcare Technologies, Inc., a Manager-Commercial Finance & Business Planning by Motorola Automotive & Industrial Electronics Group, and a Chief Financial Officer by The Lexington. He also served on the board at Trius Therapeutics, Inc. He received his undergraduate degree from the University of Wisconsin and an MBA from the University of Wisconsin.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2026-06-09 | 15,001 ( 0.01% ) | 21 301 $ | 2026-05-30 | |
| 2026-05-17 | 9,366 ( 0.02% ) | 14 986 $ | 2026-05-30 |
Michael Tomsicek active positions
| Companies | Position | Start |
|---|---|---|
| MILESTONE PHARMACEUTICALS INC. | Director/Board Member | 2019-03-31 |
| ACRIVON THERAPEUTICS, INC. | Director/Board Member | 2022-09-30 |
Optimer Pharmaceuticals LLC
 Optimer Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops and commercializes anti-infective products | Director/Board Member | 2013-10-23 |
Cimeio Therapeutics AG
 Cimeio Therapeutics AG BiotechnologyHealth Technology Operates as a biotechnology company developing shielded-cell & immunotherapy pairs, which protect genetically modified cells from targeted therapies | Director/Board Member | 2022-11-02 |
Former positions of Michael Tomsicek
| Companies | Position | End |
|---|---|---|
| CRISPR THERAPEUTICS AG | Director of Finance/CFO | 2021-10-13 |
| ABIOMED, INC. | Director of Finance/CFO | 2017-08-23 |
| CUBIST PHARMACEUTICALS INC | Director of Finance/CFO | 2014-12-31 |
General Electric Healthcare Technologies, Inc.
 General Electric Healthcare Technologies, Inc. Medical/Nursing ServicesHealth Services Provides transformational medical technologies and services | Corporate Officer/Principal | 2010-08-31 |
The Lexington
 The Lexington Medical/Nursing ServicesHealth Services Operates a 125-bed assisted living facility | Director of Finance/CFO | - |
Training of Michael Tomsicek
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
94
1st degree connections
12
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 12 |
|---|---|
ABIOMED, Inc.
 ABIOMED, Inc. Medical SpecialtiesHealth Technology Manufactures cardiac support, recovery and replacement devices | Health Technology |
Cubist Pharmaceuticals LLC
 Cubist Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Engages in research, development and commercialization of pharmaceutical products | Health Technology |
Milestone Pharmaceuticals, Inc.
 Milestone Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures cardiovascular medicines | Health Technology |
University of Wisconsin
 University of Wisconsin Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Optimer Pharmaceuticals LLC
Optimer Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops and commercializes anti-infective products | Health Technology |
Trius Therapeutics, Inc.
 Trius Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops antibacterial drugs for the treatment of infections | Health Technology |
General Electric Healthcare Technologies, Inc.
General Electric Healthcare Technologies, Inc. Medical/Nursing ServicesHealth Services Provides transformational medical technologies and services | Health Services |
The Lexington
The Lexington Medical/Nursing ServicesHealth Services Operates a 125-bed assisted living facility | Health Services |
Motorola Automotive & Industrial Electronics Group | |
CRISPR Therapeutics AG
 CRISPR Therapeutics AG BiotechnologyHealth Technology Develops gene-based medicines | Health Technology |
Acrivon Therapeutics, Inc.
 Acrivon Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical stage biopharmaceutical company that develops and sells precision oncology medicines | Health Technology |
Cimeio Therapeutics AG
Cimeio Therapeutics AG BiotechnologyHealth Technology Operates as a biotechnology company developing shielded-cell & immunotherapy pairs, which protect genetically modified cells from targeted therapies | Health Technology |
- Stock Market
- Insiders
- Michael Tomsicek
